Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 76420-818

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 76420-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rabe-str (Rabe Str)

FDA Label Image

Rabe-str2 (Rabe Str2)

This text shows a table displaying heartburn scores for different study days for individuals taking different doses of medication (PLACEBO, RAB 10mg, RAB 20mg). Heartburn scores range from 0 (None) to 4 (Very Severe).*

FDA Label Image

Rabe-str3 (Rabe Str3)

This text contains data related to a study evaluating the effectiveness of a placebo and a drug called RAB20mg. The study includes 58 participants for the placebo group and 59 participants for the RAB20mg group. It also provides a scale for heartburn scores ranging from 0 (None) to 4 (Very Severe) based on different levels of severity.*

FDA Label Image

Rabe-str4 (Rabe Str4)

The text shows a comparison between the mean scores of a placebo group and a group taking 20mg of RAB medication. The study evaluates heartburn scores based on severity levels ranging from Sight to Very Severe on different study days. Data for 59 participants in the RAB group is included.*

FDA Label Image

Label (Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.